ASM MICROBE 2016 - Therapeutics and Prevention Package

3- Advances in Study Design

Section: 1 Presentation 1 Certificate 1 Survey

4 - HIV Cohorts Studies

Section: 1 Presentation 1 Certificate 1 Survey

5 - How to Change the Reporting of Microbiology Results to Improve Antibiotic Prescribing

Section: 1 Presentation 1 Certificate 1 Survey

133 - Decreased Antibiotic Efficacy in Renal Impairment: Are We Getting the Dose Wrong? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP))

Section: 1 Presentation 1 Certificate 1 Survey

134 - Fresh Approaches to Antibiotic Drug Discovery: Breaking from Convention

Section: 1 Presentation 1 Certificate 1 Survey

205 - Carbapenemases

Section: 1 Presentation 1 Certificate 1 Survey

207 - Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance in Gram-positive Bacteria

Section: 1 Presentation 1 Certificate 1 Survey

209 - Case Management of Tropical Infectious Diseases and Travel Medicine (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH))

Section: 1 Presentation 1 Certificate 1 Survey

232 - How to Use Behavioral Theories to Design an Effective Antimicrobial Stewardship Program

Section: 1 Presentation 1 Certificate 1 Survey

246 - Clinical Mycology

Section: 1 Presentation 1 Certificate 1 Survey

247 - Innovations and Challenges in Pharmacokinetics/Pharmacodynamics (PK/PD)

Section: 1 Presentation 1 Certificate 1 Survey

257 - Encephalitis: What Is New? (Supported Jointly with the Société de Pathologie Infectieuse de Langue Française (SPILF))

Section: 1 Presentation 1 Certificate 1 Survey

261 - Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG))

Section: 1 Presentation 1 Certificate 1 Survey

263 - Pneumonia Etiology of Infants in Resource Limited Settings: 2016 Update on Diagnostics, Prevention and Treatment

Section: 1 Presentation 1 Certificate 1 Survey

267 - What’s in the Pipeline? Recently Approved and Experimental Antimicrobial Agents

Section: 1 Presentation

268 - When the Standard PK/PD Model Does not Apply

Section: 1 Presentation 1 Certificate 1 Survey

332 - Antimicrobial Stewardship II

Section: 1 Presentation 1 Certificate 1 Survey

338 - Attacking the MDR Puzzle from the Other Direction: Non-Antibiotic Approaches to Treating Bacterial Infections

Section: 1 Presentation 1 Certificate 1 Survey

343 - Environmental Enteropathy During Infancy: Malnutrition and Growth Stunting (Supported jointly by the Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH))

Section: 1 Presentation 1 Certificate 1 Survey

350 - New Frontiers in HIV Cure

Section: 1 Presentation 1 Certificate 1 Survey

358 - Who Paves the Way for Fungi: Genes or Doctors? (Organized in Cooperation with the lmmunocompromised Host Society (ICHS))

Section: 1 Presentation 1 Certificate 1 Survey

361 - Antiretroviral for Prevention

Section: 1 Presentation 1 Certificate 1 Survey

364 - From Phenotype to Molecular Detection: The Case of Carbapenemases

Section: 1 Presentation 1 Certificate 1 Survey

365 - Management of Cytomegalovirus

Section: 1 Presentation 1 Certificate 1 Survey

366 - PK/PD Optimization against Carbapenamase Producing Bacteria

Section: 1 Presentation 1 Certificate 1 Survey

371 - Antiretrovirals for Prevention and Treatment

Section: 1 Presentation 1 Certificate 1 Survey

373 - New Beta-lactamase and Carbapenemase Inhibitors

Section: 1 Presentation 1 Certificate 1 Survey

374 - RNA Modulation and Cellular Signals in Antimicrobial Resistance

Section: 1 Presentation 1 Certificate 1 Survey

376 - Aiming at Non-Conventional Approaches to TB Therapies (Supported Jointly by the Bill & Melinda Gates Foundation)

Section: 1 Presentation 1 Certificate 1 Survey

378 - Antimicrobial Toxicodynamics (Organized in Cooperation with the International Society of Anti-Infective Pharmacology (ISAP))

Section: 1 Presentation 1 Certificate 1 Survey

437 - Staphylococcus aureus Infection Treatments: New Compounds, New Strategies

Section: 1 Presentation 1 Certificate 1 Survey

439 - Clinical Update on Hepatitis

Section: 1 Presentation 1 Certificate 1 Survey

444 - Treatment of HIV Infection

Section: 1 Presentation 1 Certificate 1 Survey

445 - Tricky Choices Regarding Appropriate Antimicrobial Prescribing

Section: 1 Presentation 1 Certificate 1 Survey

230 - Difficult Viral Infections in HSCT

Section: 1 Presentation 1 Certificate 1 Survey

Items Included in the Purchase of this Product Bundle

3- Advances in Study Design

4 - HIV Cohorts Studies

5 - How to Change the Reporting of Microbiology Results to Improve Antibiotic Prescribing

14 - Antimicrobial Stewardship I

16 - New Antifungals

89 - Early New Antimicrobial Agents

92 - Novel Strategies to Help Antibiotics to Play their Role

93 - Novel Vaccines: From Basic Research Through Clinical Development

103 - The Heart of It All: Update on Endocarditis 2016

115 - Antimicrobial Breakpoints: Time for a Single CAST?

116 - Antimicrobial Discovery Approaches

119 - Top 10 Beta-lactamase Papers for 2015

128 - New insights on Emerging Resistance Mechanisms in Gram-negatives

131 - Controversies in Antimicrobial Stewardship

133 - Decreased Antibiotic Efficacy in Renal Impairment: Are We Getting the Dose Wrong? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP))

134 - Fresh Approaches to Antibiotic Drug Discovery: Breaking from Convention

205 - Carbapenemases

207 - Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance in Gram-positive Bacteria

209 - Case Management of Tropical Infectious Diseases and Travel Medicine (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH))

232 - How to Use Behavioral Theories to Design an Effective Antimicrobial Stewardship Program

246 - Clinical Mycology

247 - Innovations and Challenges in Pharmacokinetics/Pharmacodynamics (PK/PD)

257 - Encephalitis: What Is New? (Supported Jointly with the Société de Pathologie Infectieuse de Langue Française (SPILF))

261 - Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG))

263 - Pneumonia Etiology of Infants in Resource Limited Settings: 2016 Update on Diagnostics, Prevention and Treatment

267 - What’s in the Pipeline? Recently Approved and Experimental Antimicrobial Agents

268 - When the Standard PK/PD Model Does not Apply

332 - Antimicrobial Stewardship II

338 - Attacking the MDR Puzzle from the Other Direction: Non-Antibiotic Approaches to Treating Bacterial Infections

343 - Environmental Enteropathy During Infancy: Malnutrition and Growth Stunting (Supported jointly by the Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH))

350 - New Frontiers in HIV Cure

358 - Who Paves the Way for Fungi: Genes or Doctors? (Organized in Cooperation with the lmmunocompromised Host Society (ICHS))

361 - Antiretroviral for Prevention

364 - From Phenotype to Molecular Detection: The Case of Carbapenemases

365 - Management of Cytomegalovirus

366 - PK/PD Optimization against Carbapenamase Producing Bacteria

371 - Antiretrovirals for Prevention and Treatment

373 - New Beta-lactamase and Carbapenemase Inhibitors

374 - RNA Modulation and Cellular Signals in Antimicrobial Resistance

376 - Aiming at Non-Conventional Approaches to TB Therapies (Supported Jointly by the Bill & Melinda Gates Foundation)

378 - Antimicrobial Toxicodynamics (Organized in Cooperation with the International Society of Anti-Infective Pharmacology (ISAP))

437 - Staphylococcus aureus Infection Treatments: New Compounds, New Strategies

439 - Clinical Update on Hepatitis

444 - Treatment of HIV Infection

445 - Tricky Choices Regarding Appropriate Antimicrobial Prescribing

230 - Difficult Viral Infections in HSCT